Concourse Financial Group Securities, Inc. Innate Pharma Sa Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPHA
# of Institutions
11Shares Held
98.7KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY51.2KShares$95,7880.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il26.6KShares$49,7730.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7KShares$21,8060.0% of portfolio
-
Ubs Group Ag5.96KShares$11,1390.0% of portfolio
-
Gamma Investing LLC Foster City, CA2.28KShares$4,2650.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $149M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...